Publications

Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months.

Noor, RA; Thiesen, M; Mordmuller, B; MILLIGAN, P; Atuguba, F; Sirima, S; Issifou, S; BOJANG, K; Kironde, F; Tiono, A; Okech, B; Chilengi, R; Ngoa, A; Mukasa, K; Jepsen, S;

2010

Malaria journal, (2010).9 Suppl 2 10.1186/1475-2875-9-s2-p26.

Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.

Agnandji, ST; ASANTE, KP; Lyimo, J; Vekemans, J; Soulanoudjingar, SS; Owusu, R; Shomari, M; Leach, A; Fernandes, J; DOSOO, D; Chikawe, M; Issifou, S; Osei-Kwakye, K; Lievens, M; Paricek, M; Apanga, S; Mwangoka, G; Okissi, B; Kwara, E; Minja, R; Lange, J; Boahen, O; Kayan, K; Adjei, G; CHANDRAMOHAN, D; ... Abdulla, S.

2010

The Journal of infectious diseases, (2010).202 7 10.1086/656190.

Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales.

ATCHISON, C; Lopman, B; EDMUNDS, WJ;

2010

Vaccine, (2010).28 18 10.1016/j.vaccine.2010.02.060.

Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.

White, MT; Griffin, JT; RILEY, EM; DRAKELEY, CJ; Moorman, AM; Sumba, PO; Kazura, JW; Ghani, AC; John, CC;

2010

Proceedings Biological sciences / The Royal Society, (2010).278 1710 10.1098/rspb.2010.1697.

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.

JOBARTEH, M; Malfroy, M; Peterson, I; Jeng, A; Sarge-Njie, R; Alabi, A; Peterson, K; COTTEN, M; Hall, A; Rowland-Jones, S; Whittle, H; Tedder, R; Jaye, A; Mendy, M;

2010

Virology journal, (2010).7 1 10.1186/1743-422X-7-230.

Sensitivity and specificity of BCG scar reading among HIV-infected children.

Van-Dunem, JC V D; De Alencar, LC A; RODRIGUES, LC; De Albuquerque, MD F P M; Ramos, ME; Ximenes, RA D A;

2010

Vaccine, (2010).28 9 10.1016/j.vaccine.2009.12.034.

Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya.

Osier, FH A; Weedall, GD; Verra, F; Murungi, L; TETTEH, KK A; Bull, P; Faber, BW; Remarque, E; Thomas, A; Marsh, K; CONWAY, DJ;

2010

Infection and immunity, (2010).78 11 10.1128/IAI.00576-10.

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.

Weinberger, DM; Harboe, ZB; Sanders, EA M; Ndiritu, M; Klugman, KP; Rückinger, S; Dagan, R; Adegbola, R; Cutts, F; Johnson, HL; O'Brien, KL; SCOTT, JA; Lipsitch, M;

2010

Clinical infectious diseases, (2010).51 6 10.1086/655828.

Doxorubicin-loaded and antibody-conjugated liposome-QD hybrid vesicles for targeted cancer therapy and imaging.

Tian, B; Al-Jamal, WT; Van den Bossche, J; Stuart, M; RAYNES, JG; Kostarelos, K;

2010

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, (2010).240,

Estimating the proportion of pneumonia attributable to pneumococcus in Kenyan adults: latent class analysis.

Jokinen, J; SCOTT, JA G;

2010

Epidemiology (Cambridge, Mass), (2010).21 5 10.1097/EDE.0b013e3181e4c4d5.